<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32855285</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Deficits in verbal fluency in presymptomatic <i>C9orf72</i> mutation gene carriers-a developmental disorder.</ArticleTitle><Pagination><StartPage>1195</StartPage><EndPage>1200</EndPage><MedlinePgn>1195-1200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2020-323671</ELocationID><Abstract><AbstractText Label="BACKGROUND">A mutation in <i>C9orf72</i> constitute a cross-link between amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD). At clinical manifestation, both patient groups may present with either cognitive impairment of predominantly behaviour or language (in FTD) or motor dysfunctions (in ALS).</AbstractText><AbstractText Label="METHODS">In total, 36 non-symptomatic mutation carriers from ALS or FTD families were examined, including 21 subjects with <i>C9orf72</i> and 15 with <i>SOD1</i> mutations. Data were compared with 91 age-matched, education-matched and gender-matched healthy subjects (56 were first-degree relatives from ALS or FTD families, 35 with no known family history of ALS/FTD). MRI scanning for diffusion tensor imaging was performed to map fractional anisotropy (FA). Subjects performed an extensive neuropsychological assessment to address verbal fluency, language, executive, memory and visuospatial function. Measurements were repeated after 12 months.</AbstractText><AbstractText Label="RESULTS"><i>C9orf72</i> expansion carriers performed significantly worse in verbal fluency and non-verbal memory and presented with distinct alterations in structural white matter integrity indicated by lower FA values in inferior and orbitofrontal cortical areas compared with carriers of <i>SOD1</i> mutations or healthy subjects. Loss of structural integrity was associated with decreased verbal fluency performance. White matter alterations and cognitive performance showed no changes over 12 months in all subjects.</AbstractText><AbstractText Label="DISCUSSION">Reduced verbal fluency performance seems to be a distinct clinical feature of <i>C9orf72</i> carriers before symptomatic disease onset without evidence for change over time in our cohort. The results support the emerging hypothesis of a general disorder in development in addition to neurodegeneration in <i>C9orf72</i> carriers.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lul&#xe9;</LastName><ForeName>Doroth&#xe9;e E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0001-5944-398X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neuropsychology, Ulm University, Ulm, Germany dorothee.lule@uni-ulm.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finsel</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weydt</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2344-5662</Identifier><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knehr</LastName><ForeName>Antje</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winroth</LastName><ForeName>Ivar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Science, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0094-5429</Identifier><AffiliationInfo><Affiliation>Neurology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3399-9784</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uttner</LastName><ForeName>Ingo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassubek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7106-9270</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-5401-0904</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1138</RefSource><PMID Version="1">32855286</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="Y">Asymptomatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056344" MajorTopicYN="Y">Executive Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007807" MajorTopicYN="N">Language Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="Y">Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065886" MajorTopicYN="N">Neurodevelopmental Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065855" MajorTopicYN="Y">Spatial Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32855285</ArticleId><ArticleId IdType="pmc">PMC7569387</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2020-323671</ArticleId><ArticleId IdType="pii">jnnp-2020-323671</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lul&#xe9; D, B&#xf6;hm S, M&#xfc;ller H-P, et al. . Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex 2018;101:163&#x2013;71. 10.1016/j.cortex.2018.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2018.01.004</ArticleId><ArticleId IdType="pubmed">29477906</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. . Expanded GGGGCC hexanucleotide repeat in noncoding region of c9orf72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245&#x2013;56. 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, Raaphorst J, Klein Twennaar M, et al. . The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry 2016;87:611&#x2013;9. 10.1136/jnnp-2015-310734</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310734</ArticleId><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Schuster C, Machts J, et al. . Microstructural white matter changes underlying cognitive and behavioural impairment in ALS--an in vivo study using DTI. PLoS One 2014;9:e114543. 10.1371/journal.pone.0114543</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114543</ArticleId><ArticleId IdType="pmc">PMC4263750</ArticleId><ArticleId IdType="pubmed">25501028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Caga J, Lillo P, et al. . Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology 2014;82:149&#x2013;55. 10.1212/WNL.0000000000000023</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000023</ArticleId><ArticleId IdType="pubmed">24336140</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bede P, El Mendili MM, et al. . Predict to prevent frontotemporal lobar degeneration and amyotrophic lateral sclerosis Study Group. presymptomatic spinal cord pathology in c9orf72 mutation carriers: a longitudinal neuroimaging study. Ann Neurol 2019;86:158&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">31177556</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutsaerts HJMM, Mirza SS, Petr J, et al. . Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study. Brain 2019;142:1108&#x2013;20. 10.1093/brain/awz039</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz039</ArticleId><ArticleId IdType="pmc">PMC6439322</ArticleId><ArticleId IdType="pubmed">30847466</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A, Gazzina S, Premi E, et al. . Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia. Neurobiol Aging 2019;76:133&#x2013;40. 10.1016/j.neurobiolaging.2018.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.12.018</ArticleId><ArticleId IdType="pubmed">30711676</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Sias AC, Mandelli ML, et al. . Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin 2017;14:286&#x2013;97. 10.1016/j.nicl.2016.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5349617</ArticleId><ArticleId IdType="pubmed">28337409</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, Nicholas JM, Cash DM, et al. . Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the genetic frontotemporal dementia initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol 2015;14:253&#x2013;62. 10.1016/S1474-4422(14)70324-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70324-2</ArticleId><ArticleId IdType="pmc">PMC6742501</ArticleId><ArticleId IdType="pubmed">25662776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh T-H, Liu H-F, Li Y-W, et al. . C9orf72 is essential for neurodevelopment and motility mediated by cyclin G1. Exp Neurol 2018;304:114&#x2013;24. 10.1016/j.expneurol.2018.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.03.002</ArticleId><ArticleId IdType="pubmed">29522758</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Xu J. C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in Drosophila Glutamatergic Neurons. J Neurosci 2018;38:7741&#x2013;52. 10.1523/JNEUROSCI.0908-18.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0908-18.2018</ArticleId><ArticleId IdType="pmc">PMC6705968</ArticleId><ArticleId IdType="pubmed">30037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Irwin DJ, et al. . Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2014;127:423&#x2013;39. 10.1007/s00401-013-1238-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1238-y</ArticleId><ArticleId IdType="pmc">PMC3971993</ArticleId><ArticleId IdType="pubmed">24407427</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, et al. . Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nat Rev Neurol 2013;9:708&#x2013;14. 10.1038/nrneurol.2013.221</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Mackenzie IRA. Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 2019;45:19&#x2013;40. 10.1111/nan.12526</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12526</ArticleId><ArticleId IdType="pubmed">30357887</ArticleId></ArticleIdList></Reference><Reference><Citation>Akimoto C, Volk AE, van Blitterswijk M, et al. . A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. J Med Genet 2014;51:419&#x2013;24. 10.1136/jmedgenet-2014-102360</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2014-102360</ArticleId><ArticleId IdType="pmc">PMC4033024</ArticleId><ArticleId IdType="pubmed">24706941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361&#x2013;70. 10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Burkhardt C, Abdulla S, et al. . The Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:16&#x2013;23. 10.3109/21678421.2014.959451</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959451</ArticleId><ArticleId IdType="pubmed">25292386</ArticleId></ArticleIdList></Reference><Reference><Citation>Loose M, Burkhardt C, Aho-&#xd6;zhan H, et al. . Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS. Amyotroph Lateral Scler Frontotemporal Degener 2016;17:374&#x2013;6. 10.3109/21678421.2016.1162814</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1162814</ArticleId><ArticleId IdType="pubmed">27027323</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschenbrenner S, Tucha O, Lange K. Regensburger Wortfl&#xfc;ssigkeits-Test. Hogrefe-Verlag, G&#xf6;ttingen, 2000.</Citation></Reference><Reference><Citation>Regard M, Strauss E, Knapp P. Children's production on verbal and non-verbal fluency tasks. Percept Mot Skills 1982;55:839&#x2013;44. 10.2466/pms.1982.55.3.839</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pms.1982.55.3.839</ArticleId><ArticleId IdType="pubmed">7162920</ArticleId></ArticleIdList></Reference><Reference><Citation>von Cramon DY, Hebel N, Schuri U. Verbal memory and learning in unilateral posterior cerebral infarction. A report on 30 cases. Brain 1988;111(Pt 5:1061&#x2013;77. 10.1093/brain/111.5.1061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/111.5.1061</ArticleId><ArticleId IdType="pubmed">3179684</ArticleId></ArticleIdList></Reference><Reference><Citation>Baddeley A, Emslie H, Doors N-SI. People: a test of visual and verbal recall and recognition. Bury-St-Edmunds, UK: Thames Valley Test Company, 1994.</Citation></Reference><Reference><Citation>Rodewald K, Bartolovic M, Debelak R, et al. . Eine Normierungsstudie eines modifizierten TRAIL making tests Im deutschsprachigen Raum. Zeitschrift f&#xfc;r Neuropsychologie 2012;23:37&#x2013;48. 10.1024/1016-264X/a000060</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/1016-264X/a000060</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical power analysis for the behavioral sciences. Hoboken: Taylor and Francis, 1988.</Citation></Reference><Reference><Citation>Kassubek J, M&#xfc;ller H-P, Del Tredici K, et al. . Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker. J Neurol Neurosurg Psychiatry 2018;89:374&#x2013;81. 10.1136/jnnp-2017-316365</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316365</ArticleId><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Unrath A, Ludolph AC, et al. . Preservation of diffusion tensor properties during spatial normalization by use of tensor imaging and fibre tracking on a normal brain database. Phys Med Biol 2007;52:N99&#x2013;109. 10.1088/0031-9155/52/6/N01</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0031-9155/52/6/N01</ArticleId><ArticleId IdType="pubmed">17327646</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Turner MR, Grosskreutz J, et al. . A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2016;87:570&#x2013;9. 10.1136/jnnp-2015-311952</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311952</ArticleId><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriegeskorte N, Simmons WK, Bellgowan PSF, et al. . Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci 2009;12:535&#x2013;40. 10.1038/nn.2303</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2303</ArticleId><ArticleId IdType="pmc">PMC2841687</ArticleId><ArticleId IdType="pubmed">19396166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller H-P, Del Tredici K, et al. . Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain 2014;137:1733&#x2013;40. 10.1093/brain/awu090</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu090</ArticleId><ArticleId IdType="pubmed">24736303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Ziemann U, Eisen A. Amyotrophic lateral sclerosis: origins traced to impaired balance between neural excitation and inhibition in the neonatal period. Muscle Nerve 2019;60:232&#x2013;5. 10.1002/mus.26617</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26617</ArticleId><ArticleId IdType="pubmed">31233613</ArticleId></ArticleIdList></Reference><Reference><Citation>Luu TM, Ment L, Allan W, et al. . Executive and memory function in adolescents born very preterm. Pediatrics 2011;127:e639&#x2013;46. 10.1542/peds.2010-1421</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-1421</ArticleId><ArticleId IdType="pmc">PMC3065148</ArticleId><ArticleId IdType="pubmed">21300680</ArticleId></ArticleIdList></Reference><Reference><Citation>Begega A, M&#xe9;ndez L&#xf3;pez M, de Iscar MJ, et al. . Assessment of the global intelligence and selective cognitive capacities in preterm 8-year-old children. Psicothema 2010;22:648&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21044492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakubo Y, Kuwabara H, Watanabe K-I, et al. . Impaired prefrontal hemodynamic maturation in autism and unaffected siblings. PLoS One 2009;4:e6881. 10.1371/journal.pone.0006881</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0006881</ArticleId><ArticleId IdType="pmc">PMC2731203</ArticleId><ArticleId IdType="pubmed">19727389</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenkin SD, Bastin ME, MacGillivray TJ, et al. . Childhood and current cognitive function in healthy 80-year-olds: a DT-MRI study. Neuroreport 2003;14:345&#x2013;9. 10.1097/00001756-200303030-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200303030-00010</ArticleId><ArticleId IdType="pubmed">12634481</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusbaum AO, Tang CY, Buchsbaum MS, et al. . Regional and global changes in cerebral diffusion with normal aging. AJNR Am J Neuroradiol 2001;22:136&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975529</ArticleId><ArticleId IdType="pubmed">11158899</ArticleId></ArticleIdList></Reference><Reference><Citation>Deary IJ, Whiteman MC, Starr JM, et al. . The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol 2004;86:130&#x2013;47. 10.1037/0022-3514.86.1.130</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0022-3514.86.1.130</ArticleId><ArticleId IdType="pubmed">14717632</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenkin SD, Bastin ME, Macgillivray TJ, et al. . Cognitive correlates of cerebral white matter lesions and water diffusion tensor parameters in community-dwelling older people. Cerebrovasc Dis 2005;20:310&#x2013;8. 10.1159/000087930</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000087930</ArticleId><ArticleId IdType="pubmed">16141715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand A, Wen J, Rinaldi D, et al. . Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years. JAMA Neurol 2018;75:236&#x2013;45. 10.1001/jamaneurol.2017.4266</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4266</ArticleId><ArticleId IdType="pmc">PMC5838615</ArticleId><ArticleId IdType="pubmed">29197216</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin A, Akimoto C, Wuolikainen A, et al. . Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD. Hum Mol Genet 2015;24:3133&#x2013;42. 10.1093/hmg/ddv064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv064</ArticleId><ArticleId IdType="pubmed">25712133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguli M, Lee C-W, Hughes T, et al. . Who wants a free brain scan? Assessing and correcting for recruitment biases in a population-based sMRI pilot study. Brain Imaging Behav 2015;9:204&#x2013;12. 10.1007/s11682-014-9297-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-014-9297-9</ArticleId><ArticleId IdType="pmc">PMC4147027</ArticleId><ArticleId IdType="pubmed">24573773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>